Yusheng Jie
- Hepatology top 5%
- Hepatitis C virus research 25
- Liver Disease and Transplantation 3
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 3
- Neurology top 10%
- Epidemiology top 10%
- Hepatitis B Virus Studies 29
- Liver Disease Diagnosis and Treatment 28
-
- Cancer-related molecular mechanisms research 5
-
- COVID-19 diagnosis using AI 4
- Journals
- BioMed Research International (5 papers)Frontiers in Pharmacology (3 papers)Frontiers in Cellular and Infection Microbiology (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yusheng Jie
56 papers receiving 848 citations
Peers
Comparison fields: 5 of 93
- Hepatology 172
- Infectious Diseases 370
- Neurology 149
- Epidemiology 305
- Oncology 211
Countries citing papers authored by Yusheng Jie
This map shows the geographic impact of Yusheng Jie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusheng Jie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusheng Jie more than expected).
Fields of papers citing papers by Yusheng Jie
This network shows the impact of papers produced by Yusheng Jie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusheng Jie. The network helps show where Yusheng Jie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yusheng Jie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 11 | |
| 7 | 2021 | 8 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 12 | |
| 10 | 2021 | 5 | |
| 11 | 2020 | 338 | |
| 12 | 2020 | 8 | |
| 13 | 2020 | 3 | |
| 14 | 2020 | 7 | |
| 15 | 2020 | 37 | |
| 16 | 2020 | 3 | |
| 17 | 2018 | 10 | |
| 18 | 2017 | 2 | |
| 19 | 2017 | 10 | |
| 20 | 2014 | 1 |
About Yusheng Jie
Yusheng Jie is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 59 papers that have together received 861 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (29 papers), Liver Disease Diagnosis and Treatment (28 papers), Hepatitis C virus research (25 papers), COVID-19 Clinical Research Studies (6 papers), Cancer-related molecular mechanisms research (5 papers), COVID-19 diagnosis using AI (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Liver Disease and Transplantation (3 papers). The work is most often cited by research in Hepatology (172 citations), Infectious Diseases (370 citations) and Neurology (149 citations). Yusheng Jie has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jiao Gong, Jing Cao, Yutian Chong, Bo Hu, Wenxiong Xu, Yaqiong Chen, Mingkai Tan, Lianxiong Yuan, Yaling Shi and Jingyi Ou. Their work appears in journals such as BioMed Research International, Frontiers in Pharmacology, Frontiers in Cellular and Infection Microbiology, Frontiers in Medicine and BMC Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.